HomeFileStructural heart disease

Structural heart disease

View Category

Mitral valve

Three-Year Outcomes of Mitral Valve-in-Valve Therapy with Balloon-Expandable Valves in the United States

Courtesy of Dr. Juan Manuel Pérez. Mitral Valve-in-Valve (MViV) implantation with balloon-expandable valves has become a solid alternative...
Dr. Juan Manuel Pérez -
Learn More
Mitral valve

Edge-to-Edge Treatment in Cardiogenic Shock

Cardiogenic shock (CS) is characterized by severe ventricular dysfunction, most often of ischemic origin. It is frequently...
Dr. Carlos Fava -
Learn More
Left Atrial Apendix Closure

Watchman FLX and Improvement Impact vs. 2.5

Left atrial appendage occlusion (LAAO) represents an effective alternative to oral anticoagulation (OAC) in patients with non-valvular...
Dr. Omar Tupayachi -
Learn More
Chronic Ischemic cardiopathy

IVUS Assessment in Patients at High Risk of Coronary Occlusion After TAVI: Results from the ICARO Study

Courtesy of Dr. Juan Manuel Pérez. Acute coronary obstruction (ACO) is a rare but potentially fatal complication following...
Dr. Juan Manuel Pérez -
Learn More
Structural heart disease

Decompensated Aortic Stenosis: Time to TAVR Matters

Aortic stenosis prevalence is expected to increase in the coming years mainly driven by increased life expectancy....
Dr. Carlos Fava -
Learn More
Other

Transcatheter Tricuspid Valve Replacement: 1-Year Outcomes

Tricuspid regurgitation (TR) has been associated with increased mortality and functional deterioration. Even though the current guidelines...
Dr. Andrés Rodríguez -
Learn More
Mitral valve

EuroPCR 2025 | TRI-SCORE for Predicting Mortality After Tricuspid Valve TEER: The EURO TR Registry

Researchers analyzed a total of 1062 patients who underwent transcatheter edge-to-edge repair (TEER) for tricuspid regurgitation (TR). Risk...
Dr. Carlos Fava -
Learn More
Mitral valve

EuroPCR 2025 | One-Year Results of Pivotal Study in China with Dragonfly for Functional Mitral Regurgitation

Researchers assessed a total of 120 patients with symptomatic severe functional mitral regurgitation despite receiving optimal guideline-directed medical...
Dr. Carlos Fava -
Learn More